Review Article, J Liver Dis Transplant Vol: 1 Issue: 2
Gastroesophageal Reflux Disease: Current Evaluation and Management
Maxwell M Chait* | |
Columbia Doctors Medical Group, Hartsdale, NY 10530, United States | |
Corresponding author : Maxwell M Chait, MD, FACP, FACG, AGAF, FASGE Columbia Doctors Medical Group, 180 East Hartsdale Avenue, Hartsdale, NY 10530, United States Tel: +1-914-725-2010; Fax: +1-91726488 E-mail: mdgi77@aol.com |
|
Received: September 10, 2012 Accepted: September 21, 2012 Published: September 22, 2012 | |
Citation: Chait MM (2012) Gastroesophageal Reflux Disease: Current Evaluation and Management. J Liver: Dis Transplant 1:2. doi:10.4172/2325-9612.1000103 |
Abstract
Gastroesophageal Reflux Disease: Current Evaluation and Management
Gastroesophageal reflux disease (GERD) is the most common upper gastrointestinal disorder in the westernized countries. The worldwide incidence of GERD is increasing as the incidence of H.Pylori is decreasing. There are a variety of esophageal and extraesophageal complications that may be potentially life threatening. Esophageal complications include erosive esophagitis, esophageal stricture, Barrett’s esophagus and adenocarcinoma of the esophagus. Extraesophageal complications include atypical chest pain that can simulate angina pectoris; ear, nose, and throat (ENT) manifestations.